DSCAM and colorectal cancer: Animal studies corroborated the oncogenic function of DSCAM-AS1, demonstrating that knockdown or deletion of this lncRNA led to reduction of tumor size of lung, breast and colorectal cancer xenografts (reviewed in [24]).